THE SGLT2 INHIBITOR EMPAGLIFLOZIN IMPROVES DIASTOLIC FUNCTION IN A HEART FAILURE MODEL MEDIATED VIA ENHANCED MYOCARDIAL KETONE METABOLISM
2019 ◽
Vol 73
(9)
◽
pp. 684
◽
Keyword(s):
2014 ◽
Vol 32
(7)
◽
pp. 1534-1541
◽
Keyword(s):
Keyword(s):
2003 ◽
Vol 2
(1)
◽
pp. 32
Keyword(s):
2008 ◽
Vol 7
◽
pp. 102-102
Keyword(s):
Keyword(s):
Keyword(s):
1991 ◽
Vol 17
(2)
◽
pp. A133
◽
Keyword(s):